Answers are grounded in this paper and cite their sources.
Several studies have identified biomarkers associated with subsequent response to treatment in psoriatic disease. However, due to the different types of biomarkers, treatments and outcome measures used, firm conclusions cannot be drawn. Further validation is needed before any of these biomarkers translate to clinical practice.
No takes yet. Share an insight, caveat, or question.
Magee et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: